Oregon Health & Science University
Industry
- Academic and Research Institutions
Latest on Oregon Health & Science University
Autobahn Therapeutics wanted to take advantage of the neuropsychiatric benefits observed with thyroid hormone therapy without systemic side effects, so the company used its proprietary technology for
BridgeBio Pharma, Inc. employs a business model of acquiring rights to or partnering with academic and institutional research in monogenic diseases and genetic cancer indications, often forming singl
Venture capital investment in biopharmaceutical companies is booming in 2020. And while novel cancer and immuno-oncology programs continue to attract large sums, drug developers working on treatments
Top Alliance: Vir Starts To Execute On Infectious Disease Strategy Vir Biotechnology Inc. launched just 11 months ago, but has already amassed a $500 million war chest to battle infectious disease